Postoperative pain in patients undergoing inguinal hernia repair Surgery
Conditions
Interventions
Enrolled participants will be randomly assigned to TEAS, sham, or control group (1:1:1). An independent, blinded statistician will generate the block randomization scheme. The table will be managed by
Sponsors
Ministry of Science and Higher Education
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male and female patients aged 18–75 years 2. Patients undergoing elective laparoscopic mesh inguinal hernia repair 3. Body mass index 18–30 kg/m² 4. ASA classification I–III 5. Patients provide signed informed consent
Exclusion criteria
Exclusion criteria: 1. Patients with bilateral or recurrent inguinal hernia 2. Patients with a history of intolerance, hypersensitivity or abuse of opioids 3. Use of opioids in the past month 4. Use of monoamine oxidase and selective serotonin reuptake inhibitors 5. Patients wearing a cardiac pacemaker 6. Patients with clinically significant cardiovascular, pulmonary, renal, hepatic and neurological disease 7. Patients with skin infections, surgical incision or scar at the point of application of acupuncture 8. Patients who participated in other clinical trials, or received other acupuncture therapy, in the previous 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total morphine dose received in mg measured using patient-controlled analgesia (PCA) device in the postoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The number of PCA demands, measured by times the button is pressed by the patients in the postoperative period 2. Pain measured using score on the Visual Analogue Scale prior to surgery and at 4, 8, 12, 16, and 20 hours after surgery 3. The frequency of opioid-related side effects recorded by the medical staff during the postoperative observation period | — |
Countries
Germany, Poland
Outcome results
None listed